Ser646

Site Information
SRSSDEDsQAtG___ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 25311377
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 ) , non-small cell lung adenocarcinoma ( 1 )
Relevant cell line - cell type - tissue:	A549 (pulmonary) ( 1 ) , Jurkat (T lymphocyte) ( 2 ) , lung ( 1 ) , NCI-H1355 (pulmonary) ( 1 ) , NCI-H1792 (pulmonary) ( 1 ) , NCI-H23 (pulmonary) ( 1 ) , NCI-H441 (pulmonary) ( 1 )

References
1	Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P Curated Info
2	Possemato A (2008) CST Curation Set: 3661; Year: 2008; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS:pSXXXpS Curated Info